Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients.
Bracchi M, Pagani N, Dalla Pria A, Milinkovic A, Nwokolo N, Thomas L, Mandalia S, Boffito M, Moyle G. Bracchi M, et al. Among authors: mandalia s. HIV Res Clin Pract. 2021 Oct;22(5):128-139. Epub 2021 Sep 22. HIV Res Clin Pract. 2021. PMID: 34551678 Clinical Trial.
Use of Coronary Artery Calcium Scoring to Improve Cardiovascular Risk Stratification and Guide Decisions to Start Statin Therapy in People Living With HIV.
Pereira B, Mazzitelli M, Milinkovic A, Moyle G, Ranasinghe S, Mandalia S, Pozniak A, Asboe D, Nelson M, Al-Hussaini A, Boffito M. Pereira B, et al. Among authors: mandalia s. J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):98-105. doi: 10.1097/QAI.0000000000002400. J Acquir Immune Defic Syndr. 2020. PMID: 32398558
Efficacy of a nelfinavir- and nevirapine-containing salvage regimen.
Sullivan AK, Nelson MR, Shaw A, Moyle GJ, Mandalia S, Gazzard BG, Asboe D. Sullivan AK, et al. Among authors: mandalia s. HIV Clin Trials. 2000 Jul-Aug;1(1):7-12. doi: 10.1310/64pf-wk1q-96y5-axjq. HIV Clin Trials. 2000. PMID: 11590484 Clinical Trial.
Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy.
Maitland D, Jackson A, Osorio J, Mandalia S, Gazzard BG, Moyle GJ; Epivir-Ziagen (EZ) Switch Study Team. Maitland D, et al. Among authors: mandalia s. HIV Med. 2008 Oct;9(8):667-72. doi: 10.1111/j.1468-1293.2008.00618.x. Epub 2008 Jul 8. HIV Med. 2008. PMID: 18631255 Free article. Clinical Trial.
269 results